Event Details

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

KemPharm 3Q16 Corporate Update

Nov 9, 2016 from 5:00 PM to 5:00 PM EST